Pediatric phase III trial of dasiglucagon for severe hypoglycemia meets primary endpoint Sep. 25, 2019
CRISPR/Cas9-mediated editing of hepatic G6pc as new model of glycogen storage disease type 1 Sep. 25, 2019
Crysvita approved in Japan for FGF-23-related hypophosphatemic rickets and osteomalacia Sep. 23, 2019
Xeris initiates dosing in phase II study of fixed-ratio coformulation of pramlintide and insulin Sep. 23, 2019
RSS